What is Wegovy worth to your employer? Companies wrestle with obesity drugs' costs, long-term value.Market Watch • 01/10/24
Novo Nordisk A/S (NVO) Presents at J.P. Morgan 42nd Annual Healthcare Conference TranscriptSeeking Alpha • 01/09/24
Dow Jones Leader Amgen Extends Gains Past Buy Point; Ozempic Maker Novo Nordisk Breaks OutInvestors Business Daily • 01/08/24
Omega Therapeutics shares surge on obesity collaboration with Novo NordiskProactive Investors • 01/04/24
Ozempic parent Novo Nordisk enters collaboration agreements with Omega and Cellarity on new treatments for obesity managementMarket Watch • 01/04/24
Novo Nordisk faces number of overlooked trends including competition for Wegovy, warns investment bankProactive Investors • 01/03/24